Natasha Theriault is developing a bacteriophage-based vaccine platform which can be rapidly adapted against newly-emerging pathogens and safely distributed in locations regardless of cold-supply chain infrastructure.
Falling Walls
Falling Walls Science Summit 2023
Login or Register
You need to be logged in to use this feature.
Bacteriophage-Based Vaccines: Breaking the Wall of Vaccine Equity
Natasha Theriault works at Cytophage Technologies, based in Winnipeg, Canada, which specializes in the development of phage-based therapies in human health, animal health, and food security. She is also a PhD student at the University of Manitoba in the Department of Microbiology.
Further Activities to have a look at